H. Suryapranata

发表

Coronary stenting with the Genous™ Bio-Engineered R Stent™ in elderly patients.

P. Damman, A. Íñiguez, M. Klomp, 2011, Circulation journal : official journal of the Japanese Circulation Society.

Coronary Stenting With the Genous(TM) Bio-Engineered R Stent(TM) in Elderly Patients

P. Damman, A. Íñiguez, M. Klomp, 2011 .

Clinical results after coronary stenting with the Genous™ Bio-engineered R stent™: 12-month outcomes of the e-HEALING (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth) worldwide registry.

P. Damman, M. Klomp, M. Beijk, 2011, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Very short dual antiplatelet therapy after PCI and new DES: a meta-analysis of 5 randomized trials.

H. Suryapranata, G. De Luca, M. Verdoia, 2020, Revista espanola de cardiologia.

DAPT Score and the Impact of Ticagrelor Monotherapy During the Second Year After PCI.

P. Serruys, H. Suryapranata, J. Wykrzykowska, 2020, JACC. Cardiovascular interventions.

Dual Antiplatelet Therapy Duration in Acute Coronary Syndrome Patients: The State of the Art and Open Issues

H. Suryapranata, G. De Luca, M. Verdoia, 2020, Cardiovascular therapeutics.

Safety and efficacy of recombinant hirudin (CGP 39 393) versus heparin in patients with stable angina undergoing coronary angioplasty.

P. Serruys, H. Suryapranata, J. Deckers, 1993, Circulation.

Time Delay to Treatment and Mortality in Primary Angioplasty for Acute Myocardial Infarction: Every Minute of Delay Counts

Elliott M. Antman, E. Antman, J. Ottervanger, 2004, Circulation.

Randomized comparison of everolimus-eluting stents and sirolimus-eluting stents in patients with ST elevation myocardial infarction: RACES-MI trial.

H. Suryapranata, G. De Luca, T. Lanzillo, 2014, JACC. Cardiovascular interventions.

The extent of ST elevation and ST deviation as predictors of mortality in ST-segment elevation myocardial patients planned to undergo primary percutaneous coronary intervention.

J. Ottervanger, H. Suryapranata, A. V. Van't Hof, 2016, International journal of cardiology.

A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction.

J. Reiber, H. Suryapranata, M. de Boer, 1993, The New England journal of medicine.

Novel X-ray image noise reduction technology reduces patient radiation dose while maintaining image quality in coronary angiography

H. Suryapranata, M. de Boer, C. Camaro, 2015, Netherlands Heart Journal.

Coronary angioplasty in patients with non-Q wave myocardial infarction

P. Serruys, H. Suryapranata, P. D. Feyter, 1990 .

The effect of low birth weight on endothelial dysfunction in young adults: a retrospective cohort study

H. Suryapranata, E. Navarese, T. Achmad, 2014 .

The prognostic importance of heart failure and age in patients treated with primary angioplasty

H. Suryapranata, J. Henriques, J. Hoorntje, 2003, European journal of heart failure.

Patency and Reinfarction in Late-Entry Myocardial Infarct Patients Treated with Reperfusion Therapy

H. Suryapranata, A. V. Van't Hof, M. de Boer, 1997, Angiology.

Ticagrelor in the prevention of coronary and non-coronary atherothrombotic events: A comprehensive meta-analysis of 10 randomized trials.

H. Suryapranata, G. De Luca, M. Verdoia, 2019, Atherosclerosis.

Field triage in the ambulance versus referral via non-percutaneous coronary intervention centre in ST-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: A systematic review

H. Suryapranata, E. Jansma, G. De Luca, 2017, European heart journal. Acute cardiovascular care.

The influence of residential distance on time to treatment in ST-elevation myocardial infarction patients

J. Ottervanger, H. Suryapranata, M. de Boer, 2014, Netherlands Heart Journal.

Impact of aging on the effects of intracoronary adenosine, peak hyperemia and its duration during fractional flow reserve assessment

H. Suryapranata, G. De Luca, M. Verdoia, 2021, Coronary artery disease.

Impact of Age on the Functional Evaluation of Intermediate Coronary Stenoses With Instantaneous Wave-Free Ratio and Fractional Flow Reserve

H. Suryapranata, G. De Luca, M. Verdoia, 2020, Angiology.

Prognostic importance of left ventricular function after angioplasty or thrombolysis for acute myocardial infarction : Long-term results of the zwolle trial

J. Ottervanger, H. Suryapranata, M. de Boer, 2001 .

Effects of HDL-modifiers on cardiovascular outcomes: a meta-analysis of randomized trials.

H. Suryapranata, G. De Luca, M. Verdoia, 2015, Nutrition, metabolism, and cardiovascular diseases : NMCD.

Poly (l‐lactic acid) bioresorbable scaffolds versus metallic drug‐eluting stents for the treatment of coronary artery disease: A meta‐analysis of 11 randomized trials

H. Suryapranata, D. Dudek, G. De Luca, 2019, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Stenting of venous bypass grafts: a new treatment modality for patients who are poor candidates for reintervention.

H. Suryapranata, B. Strauss, P. D. de Feyter, 1991, American heart journal.

Stenting of venous bypass grafts: A new treatment modality for patients who are poor candidates for reintervention

P. Serruys, H. Suryapranata, B. Strauss, 1992 .

Impact of ST-segment depression resolution on mortality after successful mechanical reperfusion in patients with ST-segment elevation acute myocardial infarction.

J. Ottervanger, H. Suryapranata, G. De Luca, 2005, The American journal of cardiology.

Effect of coronary occlusion site on angiographic and clinical outcome in acute myocardial infarction patients treated with early coronary intervention.

J. Ottervanger, H. Suryapranata, G. Borm, 2006, The American journal of cardiology.

The association of body mass index with long-term clinical outcomes after ticagrelor monotherapy following abbreviated dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: a prespecified sub-analysis of the GLOBAL LEADERS Trial

P. Serruys, H. Suryapranata, J. Wykrzykowska, 2020, Clinical Research in Cardiology.

Safety and Efficacy of 1-Month Dual Antiplatelet Therapy (Ticagrelor + Aspirin) Followed by 23-Month Ticagrelor Monotherapy in Patients Undergoing Staged Percutaneous Coronary Intervention (A Sub-Study from GLOBAL LEADERS).

P. Serruys, H. Suryapranata, R. D. de Winter, 2020, The American journal of cardiology.

Relation of interhospital delay and mortality in patients with ST-segment elevation myocardial infarction transferred for primary coronary angioplasty.

J. Ottervanger, H. Suryapranata, G. De Luca, 2005, The American journal of cardiology.

Impact of ischemic time on post-infarction left ventricular function in ST-elevation myocardial infarction treated with primary percutaneous coronary intervention.

J. Ottervanger, H. Suryapranata, M. de Boer, 2013, International journal of cardiology.

Multicentre randomized trial comparing transport to primary angioplasty vs immediate thrombolysis vs combined strategy for patients with acute myocardial infarction presenting to a community hospital without a catheterization laboratory. The PRAGUE study.

H. Suryapranata, M. Aschermann, P. Widimsky, 2000, European heart journal.

Limitation of Infarct Size and Preservation of Left Ventricular Function After Primary Coronary Angioplast Compared With Intravenous Streptokinase in Acute Myocardial Infarction

H. Suryapranata, M. J. van den Brand, M. de Boer, 1994, Circulation.

Final results of the Randomised Evaluation of short-term DUal antiplatelet therapy in patients with acute Coronary syndromE treated with a new generation stent (REDUCE) trial.

H. Suryapranata, G. De Luca, S. Damen, 2019, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

PlA1/PlA2 polymorphism does not influence response to Gp IIb-IIIa inhibitors in patients undergoing coronary angioplasty

H. Suryapranata, G. De Luca, P. Marino, 2013, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Benefits from intracoronary as compared to intravenous abciximab administration for STEMI patients undergoing primary angioplasty: a meta-analysis of 8 randomized trials.

H. Suryapranata, G. De Luca, M. Verdoia, 2012, Atherosclerosis.

Suboptimal anticoagulation with pre-hospital heparin in ST-elevation myocardial infarction

J. Ottervanger, H. Suryapranata, M. de Boer, 2011, Thrombosis and Haemostasis.

Adjunctive mechanical devices to prevent distal embolization in patients undergoing mechanical revascularization for acute myocardial infarction: a meta-analysis of randomized trials.

G. Stone, H. Suryapranata, M. Chiariello, 2007, American heart journal.

Resting Pd/Pa and haemodynamic relevance of coronary stenosis as evaluated by fractional flow reserve

H. Suryapranata, G. De Luca, P. Marino, 2017, Coronary artery disease.

Early or late intervention in patients with transient ST‐segment elevation acute coronary syndrome: Subgroup analysis of the ELISA‐3 trial

H. Suryapranata, J. Timmer, D. Lok, 2016, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Impact of age on the comparison between short-term vs 12-month dual antiplatelet therapy in patients with acute coronary syndrome treated with the COMBO dual therapy stent: 2-Year follow-up results of the REDUCE trial.

H. Suryapranata, D. Dudek, G. De Luca, 2021, Atherosclerosis.

Long term outcome and cost-effectiveness of stenting versus balloon angioplasty for acute myocardial infarction

J. Ottervanger, H. Suryapranata, A. V. Van't Hof, 2001, Heart.

Long term outcome and coste V ectiveness of stenting versus balloon angioplasty for acute myocardial infarction

J. Ottervanger, H. Suryapranata, F. Zijlstra, 2001 .

Clinical and angiographic results with the beStent: the Registry for Optimal beStent Evaluation (ROSE) trial

P. Serruys, H. Suryapranata, A. Roguin, 2000, International journal of cardiovascular interventions.

Ventricular fibrillation in acute myocardial infarction before and during primary PCI.

J. Ottervanger, H. Suryapranata, M. de Boer, 2005, International journal of cardiology.

Distal embolic protection during percutaneous coronary intervention in patients with acute coronary syndromes: The RUBY study

H. Suryapranata, T. Koh, L. Thuesen, 2006, Acute cardiac care.

Impact of routine stenting on myocardial perfusion and the extent of myocardial necrosis in patients undergoing primary angioplasty for ST-segment elevation myocardial infarction.

J. Ottervanger, H. Suryapranata, G. De Luca, 2006, American heart journal.

Ageing, impaired myocardial perfusion, and mortality in patients with ST-segment elevation myocardial infarction treated by primary angioplasty.

J. Ottervanger, H. Suryapranata, G. De Luca, 2005, European heart journal.

Unsuccessful reperfusion in patients with ST-segment elevation myocardial infarction treated by primary angioplasty.

J. Ottervanger, H. Suryapranata, G. De Luca, 2005, American heart journal.

Incidence and clinical significance of distal embolization during primary angioplasty for acute myocardial infarction.

J. Ottervanger, H. Suryapranata, M. de Boer, 2002, European heart journal.

GENDER DIFFERENCES IN PLATELET REACTIVITY IN PATIENTS RECEIVING DUAL ANTIPLATELET THERAPY

H. Suryapranata, P. Marino, L. Barbieri, 2016 .

Switching from Clopidogrel to Prasugrel in patients undergoing PCI: A meta-analytic overview

H. Suryapranata, G. De Luca, L. Barbieri, 2015, Platelets.

Gender Differences in Platelet Reactivity in Patients Receiving Dual Antiplatelet Therapy

H. Suryapranata, P. Marino, G. Bellomo, 2016, Cardiovascular Drugs and Therapy.

Diabetes mellitus, glucose control parameters and platelet reactivity in ticagrelor treated patients.

H. Suryapranata, G. De Luca, G. Bellomo, 2016, Thrombosis research.

Acetylsalicylic acid desensitization in patients with coronary artery disease: A comprehensive overview of currently available protocols.

H. Suryapranata, G. De Luca, L. Barbieri, 2016, Vascular pharmacology.

Mean platelet volume and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor

H. Suryapranata, G. De Luca, P. Marino, 2015, Expert opinion on pharmacotherapy.

Impact of atorvastatin or rosuvastatin co-administration on platelet reactivity in patients treated with dual antiplatelet therapy.

H. Suryapranata, G. De Luca, P. Marino, 2015, Atherosclerosis.

Platelet GP IIb-IIIa Receptor Antagonists in Primary Angioplasty: Back to the Future

H. Suryapranata, A. V. Van't Hof, S. Savonitto, 2015, Drugs.

Prehospital initiation of tirofiban in patients with ST-elevation myocardial infarction undergoing primary angioplasty (On-TIME 2): a multicentre, double-blind, randomised controlled trial

J. Ottervanger, H. Suryapranata, P. Stella, 2008, The Lancet.

Drug-eluting vs bare-metal stents in primary angioplasty: a pooled patient-level meta-analysis of randomized trials.

G. Stone, H. Suryapranata, Bas L van der Hoeven, 2012, Archives of internal medicine.

A meta-analytic overview of thrombectomy during primary angioplasty.

H. Suryapranata, G. De Luca, E. Navarese, 2013, International journal of cardiology.

Evaluation of clinical outcomes after COMBO stent treatment in patients presenting with acute coronary syndrome

A. Íñiguez, M. Beijk, P. Woudstra, 2017, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Impact of adenosine A2a receptor polymorphism rs5751876 on platelet reactivity in ticagrelor treated patients

H. Suryapranata, G. De Luca, P. Marino, 2018, Pharmacological research.

Impact of diabetes on immature platelets fraction and its relationship with platelet reactivity in patients receiving dual antiplatelet therapy

H. Suryapranata, G. De Luca, P. Marino, 2016, Journal of Thrombosis and Thrombolysis.

Benefits of short-term or prolonged as compared to standard 1 year DAPT in patients with acute coronary syndrome treated with drug-eluting stents: a meta-analysis of 9 randomized trials

H. Suryapranata, G. De Luca, M. Verdoia, 2020, Journal of Thrombosis and Thrombolysis.

Duration of dual antiplatelet therapy and outcome in patients with acute coronary syndrome undergoing percutaneous revascularization: A meta-analysis of 11 randomized trials.

H. Suryapranata, G. De Luca, M. Verdoia, 2018, International journal of cardiology.

Optimal Duration of Dual Antiplatelet Therapy After DES Implantation

H. Suryapranata, G. De Luca, A. Colombo, 2016, Angiology.

Sirolimus-eluting versus paclitaxel-eluting stent in primary angioplasty: a pooled patient-level meta-analysis of randomized trials

H. Suryapranata, E. D. Lorenzo, Jae‐Hwan Lee, 2014, Journal of Thrombosis and Thrombolysis.

Time course, predictors and clinical implications of stent thrombosis following primary angioplasty

G. Stone, H. Suryapranata, Bas L van der Hoeven, 2013, Thrombosis and Haemostasis.

Impact of high-dose statins on vitamin D levels and platelet function in patients with coronary artery disease.

H. Suryapranata, G. De Luca, P. Marino, 2017, Thrombosis research.

Diagnosis of takotsubo cardiomyopathy is increasing over time in patients presenting as ST-elevation myocardial infarction

J. Ottervanger, H. Suryapranata, A. Maas, 2016, Netherlands Heart Journal.

Early ambulance initiation versus in-hospital initiation of high dose clopidogrel in ST-segment elevation myocardial infarction

J. Ottervanger, H. Suryapranata, J. T. ten Berg, 2014, Thrombosis and Haemostasis.

The effect of thrombus aspiration during primary percutaneous coronary intervention on clinical outcome in daily clinical practice

J. Ottervanger, H. Suryapranata, J. Hoorntje, 2013, Thrombosis and Haemostasis.

Vitamin D deficiency and periprocedural myocardial infarction in patients undergoing percutaneous coronary interventions.

H. Suryapranata, G. De Luca, M. Verdoia, 2018, Cardiovascular revascularization medicine : including molecular interventions.

Homocysteine and its effects on in-stent restenosis.

H. Suryapranata, M. Chiariello, G. De Luca, 2005, Circulation.

Chapter 4 Troponin T elevation and prognosis after multivessel compared to single vessel elective percutaneous coronary intervention

J. Ottervanger, H. Suryapranata, J. Hoorntje, 2008 .

Troponin T elevation and prognosis after multivessel compared with single-vessel elective percutaneous coronary intervention

J. Ottervanger, H. Suryapranata, M. de Boer, 2007, Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation.

ST-segment elevation resolution and outcome in patients treated with primary angioplasty and glucose-insulin-potassium infusion.

J. Ottervanger, H. Suryapranata, G. De Luca, 2005, American heart journal.

Benefits with drug-coated balloon as compared to a conventional revascularization strategy for the treatment of coronary and non-coronary arterial disease: a comprehensive meta-analysis of 45 randomized trials.

H. Suryapranata, G. De Luca, M. Verdoia, 2021, Vascular pharmacology.

Prevalence and predictors of high-on treatment platelet reactivity during prasugrel treatment in patients with acute coronary syndrome undergoing stent implantation.

H. Suryapranata, G. De Luca, P. Marino, 2019, Journal of cardiology.

Statin therapy and mortality in patients

J. Ottervanger, H. Suryapranata, J. Hoorntje, 2008 .

Impact of statin therapy at discharge on 1-year mortality in patients with ST-segment elevation myocardial infarction treated with primary angioplasty.

J. Ottervanger, H. Suryapranata, G. De Luca, 2006, Atherosclerosis.

Impact of diabetes on fibrinogen levels and its relationship with platelet reactivity and coronary artery disease: A single-centre study.

H. Suryapranata, G. De Luca, P. Marino, 2015, Diabetes research and clinical practice.

Efficacy and safety of drug-eluting stents in ST-segment elevation myocardial infarction: a meta-analysis of randomized trials.

G. Stone, H. Suryapranata, M. Valgimigli, 2009, International journal of cardiology.

Comparison of myocardial perfusion after successful primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction with versus without diabetes mellitus.

J. Ottervanger, H. Suryapranata, G. De Luca, 2005, The American journal of cardiology.

Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction.

J. Ottervanger, H. Suryapranata, M. de Boer, 1999, The New England journal of medicine.

Clinical impact of simultaneous complete revascularization vs. culprit only primary angioplasty in patients with st-elevation myocardial infarction and multivessel disease: a meta-analysis

H. Suryapranata, E. Navarese, S. Servi, 2011, Journal of Thrombosis and Thrombolysis.

Predictors and importance of prolonged hospital stay after primary PCI for ST elevation myocardial infarction

J. Ottervanger, H. Suryapranata, M. de Boer, 2011, Coronary artery disease.

Primary percutaneous coronary intervention for ST-elevation myocardial infarction: from clinical trial to clinical practice.

J. Ottervanger, H. Suryapranata, M. de Boer, 2009, International journal of cardiology.

Reperfusion strategies in acute ST-elevation myocardial infarction: an overview of current status.

H. Suryapranata, G. De Luca, P. Marino, 2008, Progress in cardiovascular diseases.

Impact of beta-blocker therapy at discharge on long-term mortality after primary angioplasty for ST-segment elevation myocardial infarction.

J. Ottervanger, H. Suryapranata, G. De Luca, 2005, The American journal of cardiology.

J. Ottervanger, H. Suryapranata, G. De Luca, 2004, American heart journal.

Complete revascularisation in ST-elevation myocardial infarction and multivessel disease: meta-analysis of randomised controlled trials

H. Suryapranata, P. Gurbel, R. Waksman, 2015, Heart.

Angiographic determinants of infarct size after successful percutaneous intervention for acute ST-elevation myocardial infarction: the impact of distal embolisation.

J. Ottervanger, H. Suryapranata, M. de Boer, 2002, Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation.

Coronary angioplasty in patients with unstable angina pectoris: is there a role for thrombolysis?

P. Serruys, H. Suryapranata, P. D. de Feyter, 1988, Journal of the American College of Cardiology.

Impact of transfer for primary percutaneous coronary intervention on survival and clinical outcomes (from the HORIZONS-AMI Trial).

G. Stone, H. Suryapranata, R. Mehran, 2010, The American journal of cardiology.

Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trial

P. Kolh, M. Mack, P. Serruys, 2019, The Lancet.

Transferring patients for primary angioplasty: a retrospective analysis of 104 selected high risk patients with acute myocardial infarction

H. Suryapranata, A. V. Van't Hof, M. de Boer, 1997, Heart.

Prehospital initiation of tirofi ban in patients with ST-elevation myocardial infarction undergoing primary angioplasty ( On-TIME 2 ) : a multicentre , double-blind , randomised controlled trial

J. Ottervanger, H. Suryapranata, P. Stella, 2008 .

Circumflex artery related myocardial infarction: less reperfusion therapy and large infarct size.

J. Ottervanger, H. Suryapranata, V. Roolvink, 2013, International journal of cardiology.

First‐in‐man study of a thinner‐strut sirolimus‐eluting bioresorbable scaffold (FUTURE‐I): Three‐year clinical and imaging outcomes

H. Suryapranata, Yida Tang, Yanyan Zhao, 2020, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Platelet reactivity in patients with impaired renal function receiving dual antiplatelet therapy with clopidogrel or ticagrelor.

H. Suryapranata, G. De Luca, P. Marino, 2016, Vascular pharmacology.

One year clinical outcomes in patients with insulin-treated diabetes mellitus and non-insulin-treated diabetes mellitus compared to non-diabetics after deployment of the bio-engineered COMBO stent.

A. Íñiguez, P. Woudstra, H. Suryapranata, 2017, International journal of cardiology.

Multi‐Site Coronary Vein Sampling Study on Cardiac Troponin T Degradation in Non–ST‐Segment–Elevation Myocardial Infarction: Toward a More Specific Cardiac Troponin T Assay

H. Suryapranata, W. Wodzig, F. Verheugt, 2019, Journal of the American Heart Association.

Are patients with non-ST elevation myocardial infarction undertreated?

J. Ottervanger, H. Suryapranata, A. V. Van't Hof, 2007, BMC cardiovascular disorders.

External validity of ST elevation myocardial infarction trials: The Zwolle studies

J. Ottervanger, H. Suryapranata, J. Hoorntje, 2007, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Uric acid levels and the risk of Contrast Induced Nephropathy in patients undergoing coronary angiography or PCI.

H. Suryapranata, G. De Luca, P. Marino, 2015, Nutrition, metabolism, and cardiovascular diseases : NMCD.

Meta-analysis comparing efficacy and safety of first generation drug-eluting stents to bare-metal stents in patients with diabetes mellitus undergoing primary percutaneous coronary intervention.

G. Stone, H. Suryapranata, Bas L van der Hoeven, 2013, The American journal of cardiology.

Comprehensive meta-analysis of radial vs femoral approach in primary angioplasty for STEMI.

H. Suryapranata, G. De Luca, A. Schaffer, 2013, International journal of cardiology.

Bivalirudin as compared to unfractionated heparin in patients undergoing percutaneous coronary revascularization: A meta-analysis of 22 randomized trials.

H. Suryapranata, G. De Luca, L. Barbieri, 2015, Thrombosis research.

Short and long-term safety and efficacy of polymer-free vs. durable polymer drug-eluting stents. A comprehensive meta-analysis of randomized trials including 6178 patients.

H. Suryapranata, D. Kandzari, M. de Boer, 2014, Atherosclerosis.

Paclitaxel-eluting versus bare metal stents in primary PCI: a pooled patient-level meta-analysis of randomized trials

G. Stone, H. Suryapranata, E. D. Lorenzo, 2014, Journal of Thrombosis and Thrombolysis.

Impact of high-dose statins on vitamin D levels and platelet function in patients with coronary artery disease.

H. Suryapranata, G. De Luca, P. Marino, 2016, Thrombosis research.

Impact of infarct location on left ventricular ejection fraction after correction for enzymatic infarct size in acute myocardial infarction treated with primary coronary intervention.

J. Ottervanger, H. Suryapranata, G. Borm, 2006, American heart journal.

Clinical and angiographic predictors of outcome after primary angioplasty

H. Suryapranata, M. de Boer, F. Zijlstra, 2007 .

Use, timing and outcome of coronary angiography in patients with high-risk non-ST-segment elevation acute coronary syndrome in daily clinical practice: insights from a ‘real world’ prospective registry

J. Ottervanger, H. Suryapranata, A. V. Van't Hof, 2018, Netherlands Heart Journal.

Two-year outcome after early or late Intervention in non-ST elevation acute coronary syndrome

H. Suryapranata, R. Hermanides, J. Timmer, 2017, Open Heart.

A comparison of dual vs. triple antiplatelet therapy in patients with non-ST-segment elevation acute coronary syndrome: results of the ELISA-2 trial.

J. Ottervanger, H. Suryapranata, M. de Boer, 2005, European heart journal.

Tirofiban for myocardial infarction

J. Ottervanger, H. Suryapranata, A. W. van ’t Hof, 2010, Expert opinion on pharmacotherapy.

Body Mass Index and Platelet Reactivity During Dual Antiplatelet Therapy With Clopidogrel or Ticagrelor

H. Suryapranata, G. De Luca, P. Marino, 2015, Journal of cardiovascular pharmacology.

Relationship between adenosine A2a receptor polymorphism rs5751876 and fractional flow reserve during percutaneous coronary intervention

H. Suryapranata, M. Verdoia, Elvin Khedi, 2020, Heart and Vessels.

A comparison of two invasive strategies in patients with non-ST elevation acute coronary syndromes: results of the Early or Late Intervention in unStable Angina (ELISA) pilot study. 2b/3a upstream therapy and acute coronary syndromes.

H. Suryapranata, M. de Boer, J. Hoorntje, 2003, European heart journal.

Prognostic importance of troponin T and creatine kinase after elective angioplasty.

J. Ottervanger, H. Suryapranata, M. de Boer, 2007, International journal of cardiology.

Prognostic importance of creatine kinase and creatine kinase-MB after primary percutaneous coronary intervention for ST-elevation myocardial infarction.

J. Ottervanger, H. Suryapranata, A. V. Van't Hof, 2008, American heart journal.

Non-culprit lesions detected during primary PCI: treat invasively or follow the guidelines?

J. Ottervanger, H. Suryapranata, M. de Boer, 2010 .

Mortality in patients with left ventricular ejection fraction

J. Ottervanger, H. Suryapranata, M. de Boer, 2007, The American journal of cardiology.

Safet and Efficacy of Recombinant Hirudin (CGP 39 393) Versus Heparin in Patients With Stable Angina Undergoing Coronary Angioplast

P. Serruys, H. Suryapranata, J. Deckers, 1993 .

Usefulness of repeat coronary angiography 24 hours after successful balloon angioplasty to evaluate early luminal deterioration and facilitate quantitative analysis.

P. Serruys, H. Suryapranata, J. Deckers, 1993, The American journal of cardiology.

Combination of electrocardiographic and angiographic markers of reperfusion in the prediction of infarct size in patients with ST-segment elevation myocardial infarction undergoing successful primary angioplasty.

J. Ottervanger, H. Suryapranata, G. De Luca, 2007, International journal of cardiology.

Routine upstream versus selective down stream use of tirofiban in non-ST elevation myocardial infarction patients scheduled for early invasive therapy; a randomized comparison

J. Ottervanger, H. Suryapranata, M. de Boer, 2007, Journal of Thrombosis and Thrombolysis.

Meta-analysis of randomized trials of glycoprotein IIb/IIIa inhibitors in high-risk acute coronary syndromes patients undergoing invasive strategy.

H. Suryapranata, G. De Luca, M. Verdoia, 2011, The American journal of cardiology.

Prognostic significance of residual cumulative ST-segment deviation after mechanical reperfusion in patients with ST-segment elevation myocardial infarction.

J. Ottervanger, H. Suryapranata, G. De Luca, 2005, American heart journal.

Left main coronary artery stenosis undetected by 64-slice computed tomography: a word of caution

H. Suryapranata, M. Boer, J. Wirianta, 2007, Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation.

Limitation of myocardial infarct size after primary angioplasty: is a higher patency the only mechanism?

J. Ottervanger, H. Suryapranata, M. de Boer, 1999, American heart journal.

Coronary vasodilatory action after a single dose of nicorandil.

P. Serruys, H. Suryapranata, P. D. de Feyter, 1988, The American journal of cardiology.

Meta-analysis of Randomized Trials Acute ST-Segment Elevation Myocardial Infarction : A Abciximab as Adjunctive Therapy to Reperfusion in Correction

G. Stone, H. Suryapranata, J. Tcheng, 2005 .

Hyperglycemia is an important predictor of impaired coronary flow before reperfusion therapy in ST-segment elevation myocardial infarction.

J. Ottervanger, H. Suryapranata, M. de Boer, 2005, Journal of the American College of Cardiology.

Long-term, cause-specific mortality after myocardial infarction in diabetes.

J. Ottervanger, H. Suryapranata, M. de Boer, 2004, European heart journal.

Immediate coronary angioplasty versus intravenous streptokinase in acute myocardial infarction: left ventricular ejection fraction, hospital mortality and reinfarction.

J. Ottervanger, H. Suryapranata, M. de Boer, 1994, Journal of the American College of Cardiology.

The influence of time to treatment on clinical outcome in patients with acute myocardial infarction treated with primary angioplasty

H. Suryapranata, F. Zijlstra, J. Hoorntje, 1997 .

Influence of prehospital administration of aspirin and heparin on initial patency of the infarct-related artery in patients with acute ST elevation myocardial infarction.

H. Suryapranata, M. de Boer, F. Verheugt, 2002, Journal of the American College of Cardiology.

High dose heparin as pretreatment for primary angioplasty in acute myocardial infarction: the Heparin in Early Patency (HEAP) randomized trial.

J. Ottervanger, H. Suryapranata, M. de Boer, 2000, Journal of the American College of Cardiology.

Abciximab in the Treatment of ST-Segment Elevation Myocardial Infarction—Reply

H. Suryapranata, G. Luca, 2005 .

Routine stenting for acute myocardial infarction: a randomized trial in unselected patients

J. Ottervanger, H. Suryapranata, J. Hoorntje, 2004 .

Meta-analysis of time-related benefits of statin therapy in patients with acute coronary syndrome undergoing percutaneous coronary intervention.

H. Suryapranata, M. de Boer, F. Andreotti, 2014, The American journal of cardiology.

Predictors and outcome of grade 3 ischemia in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.

H. Suryapranata, Y. Birnbaum, C. Hamm, 2011, Journal of electrocardiology.

Primary angioplasty: preprocedural pharmacological therapy.

H. Suryapranata, M. de Boer, F. Zijlstra, 2006, Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation.

Platelet PIA1/PIA2 polymorphism and the risk of periprocedural myocardial infarction in patients with acute coronary syndromes undergoing coronary angioplasty

H. Suryapranata, G. De Luca, P. Marino, 2014, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Age-dependent differences in diabetes and acute hyperglycemia between men and women with ST-elevation myocardial infarction: a cohort study

J. Ottervanger, H. Suryapranata, A. Maas, 2013, Diabetology & Metabolic Syndrome.

Three‐year clinical outcomes after dual‐therapy COMBO stent placement: Insights from the REMEDEE registry

A. Íñiguez, M. Beijk, P. Woudstra, 2019, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Influence of treatment delay on infarct size and clinical outcome in patients with acute myocardial infarction treated with primary angioplasty.

H. Suryapranata, M. de Boer, F. Zijlstra, 1998, Journal of the American College of Cardiology.

Clinical characteristics and outcome of patients with acute myocardial infarction and preinfarction angina.

H. Suryapranata, M. de Boer, F. Zijlstra, 2001, Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation.

Switching from high-dose clopidogrel to prasugrel in ACS patients undergoing PCI: a single-center experience

H. Suryapranata, P. Marino, G. Parodi, 2014, Journal of Thrombosis and Thrombolysis.

Impact of adjunctive tirofiban administration on myocardial perfusion and mortality in patients undergoing primary angioplasty for ST-segment elevation myocardial infarction

J. Ottervanger, H. Suryapranata, G. De Luca, 2005, Thrombosis and Haemostasis.

Atrial fibrillation after but not before primary angioplasty for ST-segment elevation myocardial infarction of prognostic importance

J. Ottervanger, H. Suryapranata, A. Elvan, 2012, Netherlands Heart Journal.

Proof of principle of a novel co-pulsating intra-ventricular membrane pump.

H. Suryapranata, D. Duncker, W. Morshuis, 2020, Artificial organs.

Cholecalciferol levels, inflammation and leukocytes parameters: Results from a large single-centre cohort of patients.

H. Suryapranata, G. De Luca, M. Verdoia, 2020, Clinical nutrition.

Prognostic impact of Vitamin D deficiency in patients with coronary artery disease undergoing percutaneous coronary intervention.

H. Suryapranata, G. De Luca, M. Verdoia, 2020, European journal of internal medicine.

The impact of glucose-insulin-potassium infusion in acute myocardial infarction on infarct size and left ventricular ejection fraction [ISRCTN56720616]

M. Nijsten, J. Ottervanger, H. Suryapranata, 2005, BMC medicine.

randomized trial for acute myocardial infarction: The glucose-insulin-potassium study: a Glucose-insulin-potassium infusion inpatients treated with primary angioplasty

H. Suryapranata, J. Hoorntje, F. Zijlstra, 2011 .

The predictive value of cumulative lactate dehydrogenase release within the first 72 h of acute myocardial infarction in patients treated with primary angioplasty

H. Suryapranata, M. de Boer, J. Hoorntje, 2004, Annals of clinical biochemistry.

Pharmacodynamics and safety of lefradafiban, an oral platelet glycoprotein IIb/IIIa receptor antagonist, in patients with stable coronary artery disease undergoing elective angioplasty

H. Suryapranata, J. Deckers, M. Simoons, 2001, Heart.

Dual Versus Single Antiplatelet Regimen With or Without Anticoagulation in Transcatheter Aortic Valve Replacement: Indirect Comparison and Meta-analysis.

H. Suryapranata, G. De Luca, L. Barbieri, 2017, Revista espanola de cardiologia.

Percutaneous coronary intervention vs medical treatment in stable angina: the never-ending story.

H. Suryapranata, E. Navarese, M. Kowalewski, 2014, JAMA internal medicine.

Long-term impact of multivessel disease on cause-specific mortality after ST elevation myocardial infarction treated with reperfusion therapy

J. Ottervanger, H. Suryapranata, M. de Boer, 2006, Heart.

Left Main Dissection During Primary Angioplasty for Acute Myocardial Infarction (AMI)

J. Ottervanger, H. Suryapranata, 2004 .

Angiographic predictors of left ventricular ejection fraction after successful angioplasty in acute myocardial infarction: An angiographic risk score for use in the catheterization laboratory

J. Ottervanger, H. Suryapranata, M. de Boer, 2003, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Prehospital triage for angiography-guided therapy for acute myocardial infarction.

H. Suryapranata, M. de Boer, J. Hoorntje, 2004, Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation.

Predictors of early ventricular fibrillation before reperfusion therapy for acute ST-elevation myocardial infarction.

J. Ottervanger, H. Suryapranata, M. de Boer, 2004, Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation.

Clinical presentation and outcome of patients with early, intermediate and late reperfusion therapy by primary coronary angioplasty for acute myocardial infarction.

H. Suryapranata, M. de Boer, F. Zijlstra, 1998, European heart journal.

Incidence and predictors of restenosis after successful primary coronary angioplasty for acute myocardial infarction: the importance of age and procedural result.

H. Suryapranata, M. de Boer, J. Hoorntje, 1998, American heart journal.

Mortality, reinfarction, left ventricular ejection fraction and costs following reperfusion therapies for acute myocardial infarction.

H. Suryapranata, M. Simoons, M. de Boer, 1996, European heart journal.

A cost-effective analysis of primary coronary angioplasty versus thrombolysis for acute myocardial infarction.

H. Suryapranata, M. de Boer, F. Zijlstra, 1995, The American journal of cardiology.

Primary angioplasty compared with thrombolysis in acute myocardial infarction in diabetic patients.

J. Ottervanger, H. Suryapranata, M. de Boer, 1999, Diabetes care.

ST-segment elevation myocardial infarction: Historical perspective and new horizons

H. Suryapranata, M. de Boer, F. Zijlstra, 2020, Netherlands Heart Journal.

Facilitated reperfusion with prehospital glycoprotein IIb/IIIa inhibition: predictors of complete ST-segment resolution before primary percutaneous coronary intervention in the On-TIME 2 trial: correlates of reperfusion before primary PCI.

H. Suryapranata, C. Hamm, A. Mosterd, 2011, Journal of electrocardiology.

Poor outcome after recurrent acute myocardial infarction: a plea for optimal secondary prevention.

J. Ottervanger, H. Suryapranata, M. de Boer, 2011, International journal of cardiology.

Long-term clinical outcome of ST-segment elevation myocardial infarction patients with and without diabetes

H. Suryapranata, J. Henriques, F. Zijlstra, 2008 .

Is routine stenting for acute myocardial infarction superior to balloon angioplasty? A randomised comparison in a large cohort of unselected patients

J. Ottervanger, H. Suryapranata, G. De Luca, 2005, Heart.

A randomized comparison of intra-aortic balloon pumping after primary coronary angioplasty in high risk patients with acute myocardial infarction.

H. Suryapranata, M. de Boer, F. Zijlstra, 1999, European heart journal.

Clinical and quantitative angiographic results of a randomized trial comparing direct coronary angioplasty with intravenous streptokinase in acute myocardial infarction

J. Reiber, H. Suryapranata, J. Hoorntje, 1994 .

Treatment of acute myocardial infarction [1]

R. Gibbons, H. Friedman, W. O’Neill, 1993 .

Circadian variation in myocardial perfusion and mortality in patients with ST-segment elevation myocardial infarction treated by primary angioplasty.

J. Ottervanger, H. Suryapranata, G. De Luca, 2005, American heart journal.

Impact of Diabetes on Long-Term Outcome After Primary Angioplasty

G. Stone, H. Suryapranata, Bas L van der Hoeven, 2013, Diabetes Care.

Cardiac Troponin Composition Characterization after Non ST-Elevation Myocardial Infarction: Relation with Culprit Artery, Ischemic Time Window, and Severity of Injury.

Xander M R van Wijk, H. Suryapranata, A. Wu, 2020, Clinical chemistry.

Impaired Myocardial Perfusion Is a Major Explanation of the Poor Outcome Observed in Patients Undergoing Primary Angioplasty for ST-Segment–Elevation Myocardial Infarction and Signs of Heart Failure

J. Ottervanger, H. Suryapranata, G. De Luca, 2004, Circulation.

Predictors of mortality and risk stratification in primary angioplasty Part 3

H. Suryapranata, J. Hoorntje, F. Zijlstra, 2004 .

Angiographic determination of myocardial reperfusion by primary coronary angioplasty for acute myocardial infarction.

H. Suryapranata, M. de Boer, F. Zijlstra, 2002, Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation.

Feasibility and Outcomes of Transcatheter Aortic Valve Implantation Using the Left Axillary Artery as Primary Access Site.

H. Suryapranata, M. de Boer, N. van Royen, 2019, The Annals of thoracic surgery.

Circumflex artery-related acute myocardial infarction: limited ECG abnormalities but poor outcome

J. Ottervanger, H. Suryapranata, F. Zijlstra, 2007, Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation.

Higher neutrophil-to-lymphocyte ratio (NLR) increases the risk of suboptimal platelet inhibition and major cardiovascular ischemic events among ACS patients receiving dual antiplatelet therapy with ticagrelor.

H. Suryapranata, G. De Luca, M. Verdoia, 2020, Vascular pharmacology.

Impact of neutrophil-to-lymphocyte ratio on periprocedural myocardial infarction in patients undergoing non-urgent percutaneous coronary revascularisation

H. Suryapranata, G. De Luca, P. Marino, 2016, Netherlands Heart Journal.

Angiographic findings and catheterization laboratory events in patients with primary coronary angioplasty or streptokinase therapy for acute myocardial infarction.

J. Reiber, H. Suryapranata, M. de Boer, 1995, European heart journal.

Immature platelet fraction and the extent of coronary artery disease: A single centre study.

H. Suryapranata, G. De Luca, P. Marino, 2017, Atherosclerosis.

Impact of 719Trp>Arg Polymorphism of KIF 6 Gene on Contrast Induced Nephropathy in Patients Undergoing Coronary Angiography or Percutaneous Coronary Intervention

H. Suryapranata, G. De Luca, L. Barbieri, 2022, Global heart.

Abciximab as Adjunctive Therapy to Reperfusion in Acute ST-Segment Elevation Myocardial Infarction: A Meta-analysis of Randomized Trials

G. Stone, H. Suryapranata, G. Luca, 2005 .

Impact of gender difference on vitamin D status and its relationship with the extent of coronary artery disease.

H. Suryapranata, G. De Luca, P. Marino, 2015, Nutrition, metabolism, and cardiovascular diseases : NMCD.

Comparative predictive value of infarct location, peak CK, and ejection fraction after primary PCI for ST elevation myocardial infarction

J. Ottervanger, H. Suryapranata, M. de Boer, 2009, Coronary artery disease.

Effects of chronic beta-blocker treatment on admission haemodynamics in STEMI patients treated with primary angioplasty

J. Ottervanger, H. Suryapranata, Elvin Kedhi, 2020, European heart journal. Acute cardiovascular care.

Impact of age on long-term outcome after primary angioplasty with bare-metal or drug-eluting stent (from the DESERT cooperation).

G. Stone, H. Suryapranata, Bas L van der Hoeven, 2013, The American journal of cardiology.

Non-culprit lesions detected during primary PCI: treat invasively or follow the guidelines?

J. Ottervanger, H. Suryapranata, M. de Boer, 2007, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Long-term results of the randomized comparison of everolimus-eluting stents and sirolimus-eluting stent in patients with ST elevation myocardial infarction (RACES-MI trial).

H. Suryapranata, V. Palmieri, G. De Luca, 2016, International journal of cardiology.

The influence of system delay on 30-day and on long-term mortality in patients with anterior versus non-anterior ST-segment elevation myocardial infarction: a cohort study

J. Ottervanger, H. Suryapranata, J. T. ten Berg, 2015, Open Heart.

Comparison of Outcomes and Intervention Among Patients With Non-ST-Segment Elevation Acute Myocardial Infarction of Those With a Left Circumflex Versus Those With a Non-Left Circumflex-Related Coronary Artery (From the ELISA-3 Trial).

H. Suryapranata, R. Hermanides, D. Lok, 2018, The American journal of cardiology.

Possibilities and limitations of myocardial flow reserve

H. Suryapranata, F. Zijlstra, P. Widimsky, 1994 .

Coronary vasodilatory action of elgodipine in coronary artery disease.

P. Serruys, H. Suryapranata, P. D. de Feyter, 1992, The American journal of cardiology.

Gender differences with short-term vs 12 months dual antiplatelet therapy in patients with acute coronary syndrome treated with the COMBO dual therapy stent: 2-years follow-up results of the REDUCE trial

H. Suryapranata, G. De Luca, A. V. Van't Hof, 2021, Journal of Thrombosis and Thrombolysis.

Impact of anticoagulation strategy with bivalirudin or heparin on nonaccess site bleeding in percutaneous coronary interventions: A meta‐analysis of randomized trials

H. Suryapranata, G. De Luca, L. Barbieri, 2017, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Stenting and abciximab in primary angioplasty: a review of current status.

H. Suryapranata, M. Chiariello, G. De Luca, 2005, Italian heart journal : official journal of the Italian Federation of Cardiology.

Costs of stenting for acute myocardial infarction

H. Suryapranata, J. Hoorntje, F. Zijlstra, 1998, The Lancet.

Densitometrically observed differences in elastic recoil of the three main coronary arteries after percutaneous transluminal coronary angioplasty

P. Serruys, H. Suryapranata, B. Rensing, 1990 .

Advanced age and high‐residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor

H. Suryapranata, G. De Luca, P. Marino, 2016, Journal of thrombosis and haemostasis : JTH.

Impact of diabetes on the benefits from everolimus-eluting stent as compared to first-generation drug-eluting stent in patients with ST elevation myocardial infarction

H. Suryapranata, V. Palmieri, G. De Luca, 2015, Diabetes & vascular disease research.

Achieved platelet aggregation inhibition after different antiplatelet regimens during percutaneous coronary intervention for ST-segment elevation myocardial infarction.

J. Ottervanger, H. Suryapranata, M. de Boer, 2004, Journal of the American College of Cardiology.

Impact of immature platelet fraction on platelet reactivity during prasugrel maintenance treatment

H. Suryapranata, G. De Luca, M. Verdoia, 2018, Platelets.

Impact of Long-Term Dual Antiplatelet Therapy on Immature Platelet Count and Platelet Reactivity

H. Suryapranata, G. De Luca, P. Marino, 2018, Angiology.

Parathyroid Hormone Levels and High-Residual Platelet Reactivity in Patients Receiving Dual Antiplatelet Therapy With Acetylsalicylic Acid and Clopidogrel or Ticagrelor.

H. Suryapranata, G. De Luca, P. Marino, 2016, Cardiovascular therapeutics.

Vitamin D levels and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor

H. Suryapranata, G. De Luca, P. Marino, 2016, Platelets.

Prevalence and predictors of high-on treatment platelet reactivity with ticagrelor in ACS patients undergoing stent implantation.

H. Suryapranata, G. De Luca, P. Marino, 2016, Vascular pharmacology.

Immature platelet fraction and high-on treatment platelet reactivity with ticagrelor in patients with acute coronary syndromes

H. Suryapranata, G. De Luca, P. Marino, 2016, Journal of Thrombosis and Thrombolysis.

Impact of aging on platelet reactivity in diabetic patients receiving dual antiplatelet therapy

H. Suryapranata, G. De Luca, M. Verdoia, 2019, Journal of Thrombosis and Thrombolysis.

A comparison between upfront high-dose tirofiban versus provisional use in the real-world of non-selected STEMI patients undergoing primary PCI

J. Ottervanger, H. Suryapranata, J. M. Berg, 2010, Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation.

Successful reperfusion for acute ST elevation myocardial infarction is associated with a decrease in WBC count.

J. Ottervanger, H. Suryapranata, M. de Boer, 2006, The Journal of laboratory and clinical medicine.

Impact of pre-procedural dual antiplatelet therapy on periprocedural myocardial infarction in patients undergoing percutaneous coronary interventions with adjunctive tirofiban.

H. Suryapranata, G. De Luca, L. Barbieri, 2018, Thrombosis research.

Short‐term dual antiplatelet therapy in diabetic patients admitted for acute coronary syndrome treated with a new‐generation drug‐eluting stent

H. Suryapranata, G. De Luca, M. Verdoia, 2022, Diabetes/metabolism research and reviews.

Impact of diabetes mellitus on immature platelet fraction and its association with coronary artery disease

H. Suryapranata, G. De Luca, M. Verdoia, 2020, Diabetes/metabolism research and reviews.

Pre-hospital administration of tirofiban in diabetic patients with ST-elevation myocardial infarction undergoing primary angioplasty: a sub-analysis of the On-Time 2 trial.

J. Ottervanger, H. Suryapranata, C. Hamm, 2010, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Drug-eluting stents in patients with anterior STEMI undergoing primary angioplasty: a substudy of the DESERT cooperation

G. Stone, H. Suryapranata, E. D. Lorenzo, 2014, Clinical Research in Cardiology.

Bivalirudin Versus Unfractionated Heparin in Acute Coronary Syndromes: An Updated Meta-analysis of Randomized Trials.

H. Suryapranata, G. De Luca, L. Barbieri, 2016, Revista espanola de cardiologia.

Coronary angioplasty immediately after thrombolysis in 115 consecutive patients with acute myocardial infarction.

P. Serruys, H. Suryapranata, P. D. de Feyter, 1988, American heart journal.

Low hemoglobin predicts high‐platelet reactivity and major cardiovascular ischemic events at long‐term follow‐up among ACS patients receiving dual antiplatelet therapy with ticagrelor

H. Suryapranata, G. De Luca, M. Verdoia, 2021, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

chieved Platelet Aggregation Inhibition fter Different Antiplatelet Regimens uring Percutaneous Coronary Intervention or ST-Segment Elevation Myocardial Infarction

J. Ottervanger, H. Suryapranata, J. Hoorntje, 2016 .

Platelet microaggregation inhibition in patients with acute myocardial infarction pretreated with tirofiban and relationship with angiographic and clinical outcome.

J. Ottervanger, H. Suryapranata, M. de Boer, 2006, American heart journal.

IMPACT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE ON SHORT-TERM OUTCOME IN PATIENTS WITH ST-ELEVATION MYOCARDIAL INFARCTION DURING COVID-19 PANDEMIC: INSIGHTS FROM THE INTERNATIONAL MULTICENTER ISACS-STEMI REGISTRY

H. Suryapranata, G. De Luca, C. von Birgelen, 2022, Journal of the American College of Cardiology.

Primary coronary intervention for ST-elevation myocardial infarction in Indonesia and the Netherlands: a comparison

J. Ottervanger, H. Suryapranata, J. Hoorntje, 2009, Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation.

Prediction of success and major complications during elective coronary angioplasty.

H. Suryapranata, M. de Boer, J. Hoorntje, 2001, Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation.

A multi-site coronary sampling study on CRP in non-STEMI: Novel insights into the inflammatory process in acute coronary syndromes.

H. Suryapranata, F. Verheugt, S. Damen, 2018, Atherosclerosis.

Impact of increasing dose of intracoronary adenosine on peak hyperemia duration during fractional flow reserve assessment.

H. Suryapranata, G. De Luca, L. Barbieri, 2019, International journal of cardiology.

Radial vs Femoral Approach in Acute Coronary Syndromes: A Meta- Analysis of Randomized Trials.

H. Suryapranata, G. De Luca, L. Barbieri, 2017, Current vascular pharmacology.

G. Stone, H. Suryapranata, M. Schalij, 2013, Atherosclerosis.

Ticagrelor and prasugrel in acute coronary syndrome: a single-arm crossover platelet reactivity study

H. Suryapranata, G. De Luca, M. Verdoia, 2021, Journal of cardiovascular medicine.

Gender differences in platelet reactivity in diabetic patients receiving dual antiplatelet therapy.

H. Suryapranata, G. De Luca, M. Verdoia, 2020, Cardiovascular revascularization medicine : including molecular interventions.

Vitamin D levels and platelet reactivity in diabetic patients receiving dual antiplatelet therapy.

H. Suryapranata, G. De Luca, M. Verdoia, 2019, Vascular pharmacology.

Platelet Larger Cell Ratio and High-on Treatment Platelet Reactivity During Dual Antiplatelet Therapy

H. Suryapranata, G. De Luca, P. Marino, 2015, Cardiovascular Drugs and Therapy.

Shock Index More Sensitive Than Cardiogenic Shock in ST-Elevation Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention.

J. Ottervanger, H. Suryapranata, M. de Boer, 2017, Circulation journal : official journal of the Japanese Circulation Society.

Treatment assignment in young women with spontaneous coronary artery dissection.

J. Ottervanger, H. Suryapranata, A. Maas, 2014, International journal of cardiology.

Final benefit of primary percutaneous coronary intervention for ST-elevation myocardial infarction in older patients: long-term results of a randomised trial

J. Ottervanger, H. Suryapranata, A. V. Van't Hof, 2022, Netherlands Heart Journal.

Long-term Effects of Angiopeptin Treatment in Coronary Angioplasty Reduction of Clinical Events but Not Angiographic Restenosis

H. Suryapranata, J. Heikkilä, R. Balcon, 1995 .

One year clinical follow-up of the XIENCE V Everolimus-eluting stent system in the treatment of patients with de novo native coronary artery lesions: the SPIRIT II study.

P. Serruys, H. Suryapranata, K. Rasmussen, 2007, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Platelet HPA-1 a/HPA-1 b polymorphism and the risk of periprocedural myocardial infarction in patients undergoing elective PCI

H. Suryapranata, G. De Luca, P. Marino, 2014, Platelets.

Mean platelet volume and the risk of periprocedural myocardial infarction in patients undergoing coronary angioplasty.

H. Suryapranata, G. De Luca, P. Marino, 2013, Atherosclerosis.

Contrast volume to creatinine clearance ratio for the prediction of contrast-induced nephropathy in patients undergoing coronary angiography or percutaneous intervention

H. Suryapranata, G. De Luca, P. Marino, 2016, European journal of preventive cardiology.

Pre-diabetes and the risk of contrast induced nephropathy in patients undergoing coronary angiography or percutaneous intervention.

H. Suryapranata, G. De Luca, P. Marino, 2014, Diabetes research and clinical practice.

Incidence, predictors and prognostic importance of bleeding after primary PCI for ST-elevation myocardial infarction.

J. Ottervanger, H. Suryapranata, M. de Boer, 2010 .

Aspiration thrombectomy and primary percutaneous coronary intervention

H. Suryapranata, M. Chiariello, G. De Luca, 2006, Heart.

Impact of routine stenting on clinical outcome in diabetic patients undergoing primary angioplasty for ST-segment elevation myocardial infarction.

J. Ottervanger, H. Suryapranata, G. De Luca, 2006, Diabetes care.

Comparison between stenting and balloon in elderly patients undergoing primary angioplasty for ST-segment elevation myocardial infarction.

J. Ottervanger, H. Suryapranata, G. De Luca, 2007, International journal of cardiology.

Postprocedural single-lead ST-segment deviation and long-term mortality in patients with ST-segment elevation myocardial infarction treated by primary angioplasty

J. Ottervanger, H. Suryapranata, G. De Luca, 2007, Heart.

Impact of vascular access on the development of contrast induced nephropathy in patients undergoing coronary angiography and/or percutaneous coronary intervention.

H. Suryapranata, G. De Luca, L. Barbieri, 2019, International journal of cardiology.

Aspirin desensitization in patients undergoing planned or urgent coronary stent implantation. A single-center experience.

H. Suryapranata, G. De Luca, P. Marino, 2013, International journal of cardiology.

Dual Antiplatelet Therapy for 3 or 12 Months in Patients with Non-ST-elevation MI/Unstable Angina or ST-elevation MI: Analysis of the REDUCE Trial

H. Suryapranata, G. De Luca, C. Tam, 2022, Journal of Asian Pacific Society of Cardiology.

Closure device or manual compression in patients undergoing percutaneous coronary intervention: a randomized comparison.

J. Ottervanger, H. Suryapranata, A. V. Van't Hof, 2010, The Journal of invasive cardiology.

Tako-tsubo cardiomyopathy is age-dependent in men, but not in women.

J. Ottervanger, H. Suryapranata, A. Maas, 2015, International journal of cardiology.

Primary coronary angioplasty versus intravenous streptokinase in acute myocardial infarction: differences in outcome during a mean follow‐up of 18 months

J. Ottervanger, H. Suryapranata, M. de Boer, 1994, Coronary artery disease.

The mega COMBO collaboration: An individual patient data pooled analysis of patients undergoing PCI with COMBO stent.

H. Suryapranata, R. D. de Winter, S. Saito, 2022, International journal of cardiology.

Nicorandil and Cardiovascular Performance in Patients with Coronary Artery Disease

H. Suryapranata, D. Macleod, 1992, Journal of cardiovascular pharmacology.

Prevalence and predictors of bridging of coronary arteries in a large Indonesian population, as detected by 64-slice computed tomography scan

J. Ottervanger, H. Suryapranata, J. Timmer, 2012, Netherlands Heart Journal.

Routine stenting vs. balloon angioplasty in ST-segment elevation myocardial infarction due to proximal left anterior descending coronary artery occlusion

J. Ottervanger, H. Suryapranata, G. De Luca, 2009, Journal of cardiovascular medicine.

Comparison between stenting and balloon angioplasty in patients undergoing primary angioplasty of small coronary vessels.

J. Ottervanger, H. Suryapranata, G. De Luca, 2006, American heart journal.

Impact of hypertension on clinical outcome in STEMI patients undergoing primary angioplasty with BMS or DES: insights from the DESERT cooperation.

G. Stone, H. Suryapranata, Bas L van der Hoeven, 2014, International journal of cardiology.

Relationship between time-to-reperfusion and 30-day mortality in patients with ST-segment elevation myocardial infarction treated with primary angioplasty

H. Suryapranata, J. Hoorntje, F. Zijlstra, 2003 .

Impact of age on mean platelet volume and its relationship with coronary artery disease: A single-centre cohort study

H. Suryapranata, P. Marino, G. Bellomo, 2015, Experimental Gerontology.

Pre-treatment with clopidogrel and postprocedure troponin elevation after elective percutaneous coronary intervention

J. Ottervanger, H. Suryapranata, M. de Boer, 2006, Thrombosis and Haemostasis.

Cardioprotective effects of adenosine transport inhibition during reversible ischaemia in patients with coronary artery disease.

J. Ottervanger, H. Suryapranata, F. Zijlstra, 1999, International journal of cardiovascular interventions.

Safety and efficacy outcomes of first and second generation durable polymer drug eluting stents and biodegradable polymer biolimus eluting stents in clinical practice: comprehensive network meta-analysis

H. Suryapranata, A. Finn, L. Mauri, 2013, BMJ.

Comparison of rapamycin- and paclitaxel-eluting stents in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction.

J. Ottervanger, H. Suryapranata, G. De Luca, 2009, The American journal of cardiology.

Abciximab as adjunctive therapy to reperfusion in acute ST-segment elevation myocardial infarction: a meta-analysis of randomized trials.

E. Antman, E. Topol, F. Van de Werf, 2005, JAMA.

SARS-CoV-2 Positivity, Stent Thrombosis, and 30-day Mortality in STEMI Patients Undergoing Mechanical Reperfusion

H. Suryapranata, G. De Luca, C. von Birgelen, 2022, Angiology.

Closure of a coronary fistula with a transcatheter implantable coil.

H. Suryapranata, A. Bogers, H. Pieterman, 1992, Catheterization and cardiovascular diagnosis.

Are There Differences in the Demographics and Clinical Outcomes Between Asian and European Patients Treated With the COMBO Dual Therapy Stent in the REDUCE Trial Populations?

H. Suryapranata, G. De Luca, L. Barbieri, 2022, Journal of Asian Pacific Society of Cardiology.

Acute Coronary Artery Occlusion During and After Percutaneous Transluminal Coronary Angioplasty: Frequency, Prediction, Clinical Course, Management, and Follow‐up

P. Serruys, H. Suryapranata, P. D. de Feyter, 1991, Circulation.

The importance of patency of the infarct-related artery in treatment of patients with acute myocardial infarction.

H. Suryapranata, M. de Boer, F. Zijlstra, 2003, Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation.

741-1 Clinical Experience with Heparin-Coated Stents–The Benestent II Pilot Phase 1

P. Serruys, H. Suryapranata, J. Fajadet, 1995 .

Preprocedural Thrombolysis in Myocardial Infarction (TIMI) flow significantly affects the extent of ST-segment resolution and myocardial blush in patients with acute anterior myocardial infarction treated by primary angioplasty.

J. Ottervanger, H. Suryapranata, G. De Luca, 2005, American heart journal.

Impact of Smoking Status on Mortality in STEMI Patients Undergoing Mechanical Reperfusion for STEMI: Insights from the ISACS–STEMI COVID-19 Registry

H. Suryapranata, G. De Luca, C. von Birgelen, 2022, Journal of clinical medicine.

Lanreotide reduces serum free and total insulin-like growth factor-I after angioplasty.

H. Suryapranata, H. Orskov, J. Frystyk, 1996, Circulation.

Coronary haemodynamics and vasodilatory profile of a potassium channel opener in patients with coronary artery disease.

H. Suryapranata, 1993, European heart journal.

mergency Stenting for Refract During Coronary Angioplasty nar rter cclusion

H. Suryapranata, G. Laarman, P. D. Feyter, 2022 .

Incidence and predictors of subacute thrombosis in patients undergoing primary angioplasty for an acute myocardial infarction

J. Ottervanger, H. Suryapranata, M. de Boer, 2006, Thrombosis and Haemostasis.

Randomized comparison of coronary stenting with balloon angioplasty in selected patients with acute myocardial infarction.

H. Suryapranata, M. de Boer, J. Hoorntje, 1998, Circulation.

A randomized comparison of the value of additional stenting after optimal balloon angioplasty for long coronary lesions: final results of the additional value of NIR stents for treatment of long coronary lesions (ADVANCE) study.

P. Serruys, H. Suryapranata, D. Foley, 2002, Journal of the American College of Cardiology.

Everolimus eluting stent vs first generation drug-eluting stent in primary angioplasty: A pooled patient-level meta-analysis of randomized trials.

G. Stone, H. Suryapranata, G. De Luca, 2017, International journal of cardiology.

Coronary vasodilatory action after nicorandil: a quantitative angiographic study.

P. Serruys, H. Suryapranata, 1989, The American journal of cardiology.

Time-to-treatment significantly affects the extent of ST-segment resolution and myocardial blush in patients with acute myocardial infarction treated by primary angioplasty.

J. Ottervanger, H. Suryapranata, G. De Luca, 2004, European heart journal.

Impact of diabetes on neutrophil-to-lymphocyte ratio and its relationship to coronary artery disease.

H. Suryapranata, G. De Luca, P. Marino, 2015, Diabetes & metabolism.

Symptom-onset-to-balloon time and mortality in patients with acute myocardial infarction treated by primary angioplasty.

H. Suryapranata, G. De Luca, M. de Boer, 2003, Journal of the American College of Cardiology.

Heparin-coated Palmaz-Schatz stents in human coronary arteries. Early outcome of the Benestent-II Pilot Study.

W Rutsch, P. Serruys, H. Suryapranata, 1996, Circulation.

Vitamin D levels condition the outcome benefits of renin-angiotensin system inhibitors (RASI) among patients undergoing percutaneous coronary intervention.

H. Suryapranata, M. Verdoia, M. Marcolongo, 2020, Pharmacological research.

Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial blush grade. Zwolle Myocardial Infarction Study Group.

H. Suryapranata, M. de Boer, F. Zijlstra, 1998, Circulation.

Association of lower vitamin D levels with inflammation and leucocytes parameters in patients with and without diabetes mellitus undergoing coronary angiography

H. Suryapranata, G. De Luca, M. Verdoia, 2020, European journal of clinical investigation.

Inhibition of delta-protein kinase C by delcasertib as an adjunct to primary percutaneous coronary intervention for acute anterior ST-segment elevation myocardial infarction: results of the PROTECTION AMI Randomized Controlled Trial.

D. Atar, H. White, H. Suryapranata, 2014, European heart journal.

Glycosylated hemoglobin and the risk of periprocedural myocardial infarction in non-diabetic patients.

H. Suryapranata, G. De Luca, P. Marino, 2015, Journal of diabetes and its complications.

Neutrophil to Lymphocyte Ratio and the Extent of Coronary Artery Disease

H. Suryapranata, G. De Luca, P. Marino, 2016, Angiology.

Change of white blood cell count more prognostic important than baseline values after primary percutaneous coronary intervention for ST elevation myocardial infarction.

J. Ottervanger, H. Suryapranata, M. de Boer, 2008, Thrombosis research.

Prognostic value of erythrocyte sedimentation rate in ST segment elevation myocardial infarction: interaction with hyperglycaemia

J. Ottervanger, H. Suryapranata, F. Zijlstra, 2005, Journal of internal medicine.

Predictors of 30-day and 1-year mortality after primary percutaneous coronary intervention for ST-elevation myocardial infarction

J. Ottervanger, H. Suryapranata, M. de Boer, 2009, Coronary artery disease.

Feasibility and benefit of prehospital diagnosis, triage, and therapy by paramedics only in patients who are candidates for primary angioplasty for acute myocardial infarction.

J. Ottervanger, H. Suryapranata, M. de Boer, 2006, American Heart Journal.

Facilitation of primary coronary angioplasty by early start of a glycoprotein 2b/3a inhibitor: results of the ongoing tirofiban in myocardial infarction evaluation (On-TIME) trial.

H. Suryapranata, M. de Boer, J. Hoorntje, 2004, European heart journal.

Relationship between patient's risk profile and benefits in mortality from adjunctive abciximab to mechanical revascularization for ST-segment elevation myocardial infarction: a meta-regression analysis of randomized trials.

E. Topol, G. Stone, H. Suryapranata, 2006, Journal of the American College of Cardiology.

Prognostic value of admission glucose in non-diabetic patients with myocardial infarction.

J. Ottervanger, H. Suryapranata, M. de Boer, 2004, American heart journal.

Folate therapy and in-stent restenosis after coronary stenting.

H. Suryapranata, G. De Luca, H. Lange, 2004, The New England journal of medicine.

Folate Therapy and In-Stent Restenosis after Coronary Stenting

H. Suryapranata, H. Lange, J. Dambrink, 2004 .

Impact of sex on uric acid levels and its relationship with the extent of coronary artery disease: A single-centre study.

H. Suryapranata, G. De Luca, P. Marino, 2015, Atherosclerosis.

Reperfusion therapy in elderly patients with acute myocardial infarction: a randomized comparison of primary angioplasty and thrombolytic therapy.

J. Ottervanger, H. Suryapranata, M. de Boer, 2002, Journal of the American College of Cardiology.

The Na(+)/H(+) exchange inhibitor eniporide as an adjunct to early reperfusion therapy for acute myocardial infarction. Results of the evaluation of the safety and cardioprotective effects of eniporide in acute myocardial infarction (ESCAMI) trial.

H. Suryapranata, T. Machnig, G. Linssen, 2001, Journal of the American College of Cardiology.

Glucose-insulin-potassium infusion inpatients treated with primary angioplasty for acute myocardial infarction: the glucose-insulin-potassium study: a randomized trial.

Felix Zijlstra, Jan-Henk E Dambrink, H. Suryapranata, 2003, Journal of the American College of Cardiology.

and outcome? Does angiography six months after coronary intervention influence management

P. Serruys, H. Suryapranata, F. Fernández‐Avilés, 2011 .

Argatroban during percutaneous transluminal coronary angioplasty: Results of a dose-verification study

P. Serruys, H. Suryapranata, J. R. Herrman, 1996, Journal of Thrombosis and Thrombolysis.

Prevention of distal embolization in patients undergoing mechanical revascularization for acute myocardial infarction

H. Suryapranata, M. Chiariello, G. De Luca, 2006, Thrombosis and Haemostasis.

Coronary stenting and abciximab in primary angioplasty for ST-segment-elevation myocardial infarction.

H. Suryapranata, M. Chiariello, G. De Luca, 2005, QJM : monthly journal of the Association of Physicians.

Old Age and Outcome After Primary Angioplasty for Acute Myocardial Infarction

J. Ottervanger, H. Suryapranata, M. de Boer, 2010, Journal of the American Geriatrics Society.

Evaluation of the Safety and Cardioprotective Effects of Eniporide, a Specific Sodium/Hydrogen Exchange Inhibitor, Given as Adjunctive Therapy to Reperfusion in Patients with Acute Myocardial Infarction

Grzegorz Opolski, John Davies, Ulrich Tebbe, 2001, Heart Drug.

Is the difference in outcome between men and women treated by primary percutaneous coronary intervention age dependent? Gender difference in STEMI stratified on age

J. Ottervanger, H. Suryapranata, A. Maas, 2013, European heart journal. Acute cardiovascular care.

Stent implantation in very small coronary arteries: the Tsunami SV International Registry.

H. Suryapranata, H. Tan, D. Antoniucci, 2004, The American journal of cardiology.

The effect of completeness of revascularization on event-free survival at one year in the ARTS trial.

P. Serruys, E. Ribeiro, H. Suryapranata, 2002, Journal of the American College of Cardiology.

Randomized Comparison Between Stenting and Off-Pump Bypass Surgery in Patients Referred for Angioplasty

Diederick Grobbee, Erik Buskens, Cornelius Borst, 2003, Circulation.

Cardiogenic Shock Predicts Long‐term Mortality in Hospital Survivors of STEMI Treated With Primary Percutaneous Coronary Intervention

J. Ottervanger, H. Suryapranata, Elvin Kedhi, 2016, Clinical cardiology.

Angiographic Assessment of Reperfusion in Acute Myocardial Infarction by Myocardial Blush Grade

Felix Zijlstra, Jan-Henk E Dambrink, H. Suryapranata, 2003, Circulation.

Randomized comparison of primary coronary angioplasty with thrombolytic therapy in low risk patients with acute myocardial infarction.

H. Suryapranata, M. de Boer, J. Hoorntje, 1997, Journal of the American College of Cardiology.

Long-term recovery of left ventricular function after primary angioplasty for acute myocardial infarction.

J. Ottervanger, H. Suryapranata, M. de Boer, 2001, European heart journal.

Comparison of usefulness of C-reactive protein versus white blood cell count to predict outcome after primary percutaneous coronary intervention for ST elevation myocardial infarction.

J. Ottervanger, H. Suryapranata, M. de Boer, 2008, The American journal of cardiology.

Percutaneous Versus Surgical Revascularization for Left Main or Multivessel Coronary Artery Disease: Results From a Large-Scale Meta-Analysis in the Era of Drug-Eluting Stents

H. Suryapranata, G. De Luca, L. Barbieri, 2018, Angiology.

Long-term comparison of balloon angioplasty with provisional stenting versus routine stenting in patients with non-ST-elevation acute coronary syndrome

H. Suryapranata, J. Hoorntje, D. Schellings, 2010, Netherlands Heart Journal.

Predictors and clinical implications of early reinfarction after primary angioplasty for ST-segment elevation myocardial infarction.

J. Ottervanger, H. Suryapranata, G. De Luca, 2006, American heart journal.

Preprocedural TIMI flow and mortality in patients with acute myocardial infarction treated by primary angioplasty.

H. Suryapranata, G. De Luca, M. de Boer, 2004, Journal of the American College of Cardiology.

Clinical and quantitative angiographic outcomes following elective implantation of the self-expanding Wallstent for longer coronary artery lesions--final results of the Wellstent native study.

H. Suryapranata, B. Meier, C. Hanet, 1999, International journal of cardiovascular interventions.

Outcome in patients treated with primary angioplasty for acute myocardial infarction due to left main coronary artery occlusion.

H. Suryapranata, G. De Luca, M. de Boer, 2003, The American journal of cardiology.

Twelve-month outcomes after coronary stenting with the Genous™ bio-engineered R Stent™ in diabetic patients from the e-HEALING registry.

P. Damman, M. Klomp, M. Beijk, 2011, Journal of interventional cardiology.

CORONARY ARTERY DISEASE Twelve-month Outcomes After Coronary Stenting

M. Klomp, M. Beijk, S. Silber, 2011 .

Renin-angiotensin system inhibitors and mortality among diabetic patients with STEMI undergoing mechanical reperfusion during the COVID-19 pandemic

H. Suryapranata, G. De Luca, C. von Birgelen, 2021, Diabetes Epidemiology and Management.

Meta-analysis of 14 trials comparing bypass grafting vs drug-eluting stents in diabetic patients with multivessel coronary artery disease.

H. Suryapranata, G. De Luca, M. Verdoia, 2014, Nutrition, metabolism, and cardiovascular diseases : NMCD.

Applying the National Institute for Clinical Excellence criteria to patients treated with the Genous™ Bio-engineered R stent™: a sub-study of the e-HEALING (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth) worldwide registry

P. Damman, M. Klomp, M. Beijk, 2012, Heart and Vessels.

Multicenter evaluation of the phosphorylcholinecoated biodivYsio stent in short de novo coronary lesions: The SOPHOS study

H. Suryapranata, C. Hanet, P. Serruys, 2000, International journal of cardiovascular interventions.

Coronary stenting versus balloon angioplasty for acute myocardial infarction: a meta-regression analysis of randomized trials.

G. Stone, H. Suryapranata, G. Biondi-Zoccai, 2008, International journal of cardiology.

Randomised comparison of coronary stenting with balloon angioplasty in selected patients with acute myocardial infarction

H. Suryapranata, J. Hoorntje, F. Zijlstra, 1998 .

Impact of vessel size on distal embolization, myocardial perfusion and clinical outcome in patients undergoing primary angioplasty for ST-segment elevation myocardial infarction

J. Ottervanger, H. Suryapranata, J. Hoorntje, 2009, Journal of Thrombosis and Thrombolysis.

Primary percutaneous coronary intervention versus thrombolytic treatment: long term follow up according to infarct location

J. Ottervanger, H. Suryapranata, M. de Boer, 2005, Heart.

Relationship between homocysteine and coronary artery disease. Results from a large prospective cohort study.

H. Suryapranata, G. De Luca, P. Marino, 2014, Thrombosis research.

Fractional Flow Reserve-Guided Deferred Versus Complete Revascularization in Patients With Diabetes Mellitus.

J. Ottervanger, H. Suryapranata, Elvin Kedhi, 2016, The American journal of cardiology.

Clinical outcomes of deferred revascularisation using fractional flow reserve in patients with and without diabetes mellitus

J. Ottervanger, H. Suryapranata, Elvin Kedhi, 2016, Cardiovascular Diabetology.

Prognostic implications of myocardial injury around percutaneous coronary interventions

J. Ottervanger, H. Suryapranata, M. de Boer, 2008 .

H. Suryapranata, G. De Luca, C. von Birgelen, 2022, Journal of the American College of Cardiology.

COVID-19 pandemic, mechanical reperfusion and 30-day mortality in ST elevation myocardial infarction

H. Suryapranata, G. De Luca, C. von Birgelen, 2021, Heart.

Women Make the Difference in Heart Disease

H. Suryapranata, A. Maas, 2011 .

Effect of paclitaxel elution from reservoirs with bioabsorbable polymer compared to a bare metal stent for the elective percutaneous treatment of de novo coronary stenosis: the EUROSTAR-II randomised clinical trial.

P. Serruys, S. Silber, H. Suryapranata, 2011, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Angiography guided therapy in an all comer acute coronary syndrome patient population.

J. Ottervanger, H. Suryapranata, M. de Boer, 2013, International journal of cardiology.

Statins and Risk of New-Onset Diabetes Mellitus: is there a Rationale for Individualized Statin Therapy?

H. Suryapranata, E. Navarese, J. Kubica, 2013, American Journal of Cardiovascular Drugs.

Randomised comparison of drug-eluting versus bare-metal stenting in patients with non-ST elevation myocardial infarction

J. Ottervanger, H. Suryapranata, R. Hermanides, 2016, Open Heart.

Use of Metformin and Platelet Reactivity in Diabetic Patients Treated with Dual Antiplatelet Therapy.

H. Suryapranata, G. De Luca, M. Verdoia, 2018, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

Serum uric acid levels during dual antiplatelet therapy with ticagrelor or clopidogrel: Results from a single-centre study.

H. Suryapranata, G. De Luca, P. Marino, 2016, Nutrition, metabolism, and cardiovascular diseases : NMCD.

Uric acid and high-residual platelet reactivity in patients treated with clopidogrel or ticagrelor.

H. Suryapranata, G. De Luca, P. Marino, 2016, Nutrition, metabolism, and cardiovascular diseases : NMCD.

Absolute eosinophils count and the extent of coronary artery disease: a single centre cohort study

H. Suryapranata, G. De Luca, P. Marino, 2015, Journal of Thrombosis and Thrombolysis.

Efficacy and Safety of Stents in ST-Segment Elevation Myocardial Infarction.

P. Serruys, G. Stone, L. Räber, 2019, Journal of the American College of Cardiology.

Homocysteine Levels Influence Platelet Reactivity in Coronary Artery Disease Patients Treated With Acetylsalicylic Acid

H. Suryapranata, G. De Luca, P. Marino, 2015, Journal of cardiovascular pharmacology.

Factors associated with deferred lesion failure following fractional flow reserve assessment in patients with diabetes mellitus

J. Ottervanger, H. Suryapranata, R. Hermanides, 2017, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

UvA-DARE ( Digital Academic Repository ) Coronary Stenting With the Genous ( TM ) Bio-Engineered R Stent ( TM ) in Elderly Patients Damman

P. Damman, A. Íñiguez, M. Klomp, 2011 .

Usefulness of updated logistic clinical SYNTAX score based on MI‐SYNTAX score in patients with ST‐elevation myocardial infarction

P. Serruys, H. Suryapranata, R. D. de Winter, 2020, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Histological features 3 to 320 days after stenting of human saphenous vein bypass grafts

H. Suryapranata, B. Strauss, P. Serruys, 1991 .

Randomized Comparison of the Nobori Biolimus A9-Eluting Coronary Stent With the Taxus Liberté Paclitaxel-Eluting Coronary Stent in Patients With Stenosis in Native Coronary Arteries: The NOBORI 1 Trial—Phase 2

P. Serruys, S. Silber, H. Suryapranata, 2009, Circulation. Cardiovascular interventions.

High-Density Lipoproteins and Coronary Artery Disease

H. Suryapranata, P. Marino, L. Barbieri, 2014, Angiology.

Early Discharge After Primary Percutaneous Coronary Intervention: The Added Value of N‐Terminal Pro–Brain Natriuretic Peptide to the Zwolle Risk Score

H. Suryapranata, E. Giannitsis, C. Hamm, 2014, Journal of the American Heart Association.

Rationale and Design

J. Ottervanger, H. Suryapranata, C. Indolfi, 2022 .

Comparative Assessment of Predictive Performance of PRECISE-DAPT, CRUSADE, and ACUITY Scores in Risk Stratifying 30-Day Bleeding Events

P. Serruys, H. Suryapranata, R. D. de Winter, 2020, Thrombosis and Haemostasis.

Is ischemia the only factor predicting cardiovascular outcomes in all diabetes mellitus patients?

H. Suryapranata, Elvin Kedhi, E. Fabris, 2017, Cardiovascular Diabetology.

First-generation versus second-generation drug-eluting stents in current clinical practice: updated evidence from a comprehensive meta-analysis of randomised clinical trials comprising 31 379 patients

H. Suryapranata, D. Kandzari, G. Musumeci, 2014, Open Heart.

H. Suryapranata, G. De Luca, C. von Birgelen, 2023, Journal of Clinical Medicine.

Gender Difference in the Effects of COVID-19 Pandemic on Mechanical Reperfusion and 30-Day Mortality for STEMI: Results of the ISACS-STEMI COVID-19 Registry

H. Suryapranata, G. De Luca, C. von Birgelen, 2023, Journal of clinical medicine.

Polymer free vs polymer-coated drug-eluting stents for the treatment of coronary artery disease: A meta-analysis of 16 randomized trials.

H. Suryapranata, D. Dudek, G. De Luca, 2020, Cardiovascular revascularization medicine : including molecular interventions.

Gender Difference in the Risk of Contrast-Induced Nephropathy in Patients Undergoing Coronary Angiography or Percutaneous Coronary Intervention

H. Suryapranata, G. De Luca, P. Marino, 2017, Angiology.

Risk and Benefits of Triple Therapy in Patients Undergoing Coronary Stent Implantation Requiring Oral Anticoagulation: A Meta-Analysis of 16 Studies

H. Suryapranata, L. Barbieri, M. Verdoia, 2016, Cardiovascular Drugs and Therapy.

Randomized evaluation of short-term dual antiplatelet therapy in patients with acute coronary syndrome treated with the COMBO dual therapy stent: rationale and design of the REDUCE trial.

H. Suryapranata, G. De Luca, M. de Boer, 2016, American heart journal.

Impact of Diabetes on Homocysteine Levels and Its Relationship with Coronary Artery Disease: A Single-Centre Cohort Study

H. Suryapranata, G. De Luca, L. Barbieri, 2016, Annals of Nutrition and Metabolism.

Elevated Homocysteine and the Risk of Contrast-Induced Nephropathy

H. Suryapranata, G. Niccoli, P. Marino, 2015, Angiology.

Eosinophils count and periprocedural myocardial infarction in patients undergoing percutaneous coronary interventions.

H. Suryapranata, G. De Luca, P. Marino, 2014, Atherosclerosis.

NT-proBNP during and after primary PCI for improved scheduling of early hospital discharge

H. Suryapranata, A. Elvan, E. Giannitsis, 2016, Netherlands Heart Journal.

Prognostic Assessment of Patients With Acute Myocardial Infarction Treated With Primary Angioplasty: Implications for Early Discharge

Felix Zijlstra, J. Ottervanger, H. Suryapranata, 2004, Circulation.

Absence of seasonal variation in myocardial perfusion, enzymatic infarct size, and mortality in patients with ST-segment elevation myocardial infarction treated with primary angioplasty.

J. Ottervanger, H. Suryapranata, G. De Luca, 2005, The American journal of cardiology.

A quantitative analysis of the benefits of pre-hospital infarct angioplasty triage on outcome in patients undergoing primary angioplasty for acute myocardial infarction

H. Suryapranata, J. Hoorntje, F. Zijlstra, 2005 .

Two‐year safety evaluation of a biodegradable polymer sirolimus‐eluting stent with increased drug elution and polymer absorption kinetics in complex patient and lesion cohort

H. Suryapranata, C. Guan, Jin-qing Yuan, 2020, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Application of quantitative coronary angiography in the study of pharmacologically induced coronary vasomotion

P. Serruys, H. Suryapranata, 1994 .

Prehospital triage in the ambulance reduces infarct size and improves clinical outcome.

J. Ottervanger, H. Suryapranata, M. de Boer, 2011, American heart journal.

Twelve-month clinical outcomes after coronary stenting with the Genous Bio-engineered R Stent in patients with a bifurcation lesion: from the e-HEALING (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth) registry

P. Damman, M. Klomp, M. Beijk, 2012, Coronary artery disease.

Long-term performance of the COMBO dual-therapy stent: Results from the REMEDEE Registry.

A. Íñiguez, M. Beijk, P. Woudstra, 2020, Cardiovascular revascularization medicine : including molecular interventions.

Duration of dual antiplatelet therapy and outcomes after coronary stenting with the genous™ bio‐engineered R stent™ in patients from the e‐healing registry

P. Damman, M. Klomp, M. Beijk, 2012, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

1-Year Results of the REMEDEE Registry: Clinical Outcomes After Deployment of the Abluminal Sirolimus-Coated Bioengineered (Combo) Stent in a Multicenter, Prospective All-Comers Registry.

A. Íñiguez, P. Woudstra, H. Suryapranata, 2016, JACC. Cardiovascular interventions.

Randomised comparison of Nobori, biolimus A9-eluting coronary stent with a Taxus(R), paclitaxel-eluting coronary stent in patients with stenosis in native coronary arteries: the Nobori 1 trial.

P. Serruys, S. Silber, H. Suryapranata, 2007, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Flow and ortality in Patients With Acute yocardial Infarction Treated by Primary Angioplasty

H. Suryapranata, J. Hoorntje, F. Zijlstra, 2016 .

Comparison between ticlopidine and clopidogrel in patients with ST-segment elevation myocardial infarction treated with coronary stenting

J. Ottervanger, H. Suryapranata, G. De Luca, 2004, Thrombosis and Haemostasis.

Impact of the Polymorphism rs5751876 of the Purinergic Receptor ADORA2A on Periprocedural Myocardial Infarction in Patients Undergoing Percutaneous Coronary Intervention

H. Suryapranata, D. Dudek, G. De Luca, 2020, Journal of atherosclerosis and thrombosis.

Adjunctive abciximab to reperfusion therapy in patients with acute st-segment elevation myocardial infarction: A meta-analysis of randomized trials

E. Antman, G. Stone, H. Suryapranata, 2005 .

Two-year clinical outcomes of patients treated with the dual-therapy stent in a 1000 patient all-comers registry

A. Íñiguez, M. Beijk, P. Woudstra, 2017, Open Heart.

DUAL ANTIPLATELET THERAPY VERSUS SINGLE ANTIPLATELET REGIMEN WITH OR WITHOUT ANTICOAGULATION IN TRANSCATHETER AORTIC VALVE REPLACEMENT: INDIRECT COMPARISON AND META-ANALYSIS

H. Suryapranata, P. Marino, L. Barbieri, 2017 .

"PRAGUE" randomized clinical trials: pride of Czech cardiology

H. Suryapranata, P. Widimsky, 2009 .

Recent Advances in Optimal Adjunctive Antithrombotic Therapy in STEMI Patients Undergoing Primary Angioplasty: An Overview.

H. Suryapranata, G. De Luca, 2015, Current vascular pharmacology.

Bmc Cardiovascular Disorders Are Patients with Non-st Elevation Myocardial Infarction Undertreated?

J. Ottervanger, H. Suryapranata, M. de Boer, 2007 .

Bmc Cardiovascular Disorders Are Patients with Non-st Elevation Myocardial Infarction Undertreated?

J. Ottervanger, H. Suryapranata, M. de Boer, 2007 .

Short-term dual antiplatelet therapy in patients with acute coronary syndrome treated with the COMBO™ dual-therapy stent: what we plan to learn from REDUCE.

H. Suryapranata, G. De Luca, 2015, Future cardiology.

Long-term benefit of primary angioplasty compared to thrombolytic therapy for acute myocardial infarction.

J. Ottervanger, H. Suryapranata, J. Hoorntje, 2000, European heart journal.

Final five‐year results of the REMEDEE Registry: Real‐world experience with the dual‐therapy COMBO stent

A. Íñiguez, M. Beijk, P. Woudstra, 2020, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Versus Unfractionated Heparin in Acute Coronary Syndromes : An Updated Meta-analysis of Randomized Trials

H. Suryapranata, L. Barbieri, M. Verdoia, 2019 .

Are patients with non-ST elevation myocardial infarction undertreated?

J. Ottervanger, H. Suryapranata, M. de Boer, 2007, BMC cardiovascular disorders.

It’s a small world after all

H. Suryapranata, M. de Boer, H. Suryapranata, 2012, Netherlands Heart Journal.

H. Suryapranata, G. De Luca, C. von Birgelen, 2023, Journal of clinical medicine.

Percutaneous transluminal angioplasty of a totally occluded venous bypass graft: a challenge that should be resisted.

P. Serruys, H. Suryapranata, P. D. de Feyter, 1989, The American journal of cardiology.

UvA-DARE ( Digital Academic Repository ) PCI of complex coronary lesions , new stent technologies , and clinical outcomes

P. Damman, M. Klomp, M. Beijk, 2011 .

Versus Unfractionated Heparin in Acute Coronary Syndromes : An Updated Meta-analysis of Randomized Trials

H. Suryapranata, L. Barbieri, M. Verdoia, 2019 .

Quantitative angiographic assessment of elastic recoil after percutaneous transluminal coronary angioplasty.

P. Serruys, H. Suryapranata, P. D. de Feyter, 1990, The American journal of cardiology.

Continued benefit of coronary stenting versus balloon angioplasty: one-year clinical follow-up of Benestent trial. Benestent Study Group.

P W Serruys, R Simon, P. Serruys, 1996, Journal of the American College of Cardiology.

Prognostic implications of myocardial injury around percutaneous coronary interventions

J. Ottervanger, H. Suryapranata, H. Bilo, 2008 .

Impact of renal failure and high-platelet reactivity on major cardiovascular ischemic events among patients with acute coronary syndrome receiving dual antiplatelet therapy with ticagrelor.

H. Suryapranata, G. De Luca, A. Rognoni, 2022, Minerva cardiology and angiology.

Short-, medium-, and long-term follow-up after percutaneous transluminal coronary angioplasty for stable and unstable angina pectoris.

Rotterdam, P. Serruys, H. Suryapranata, 1989, American heart journal.

Impact of aging on platelet reactivity in diabetic patients receiving dual antiplatelet therapy

H. Suryapranata, G. De Luca, M. Verdoia, 2019, Journal of Thrombosis and Thrombolysis.

Vitamin D levels and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor

H. Suryapranata, G. De Luca, P. Marino, 2016, Platelets.

Body Mass Index and Platelet Reactivity During Dual Antiplatelet Therapy With Clopidogrel or Ticagrelor

H. Suryapranata, G. De Luca, P. Marino, 2015, Journal of cardiovascular pharmacology.

Relationship between homocysteine and coronary artery disease. Results from a large prospective cohort study.

H. Suryapranata, G. De Luca, P. Marino, 2014, Thrombosis research.

Acute complications of percutaneous transluminal coronary angioplasty for total occlusion.

P. Serruys, H. Suryapranata, P. D. de Feyter, 1991, American heart journal.

Prognostic value of admission glucose in non-diabetic patients with myocardial infarction.

J. Ottervanger, H. Suryapranata, M. de Boer, 2004, American heart journal.

Acetylsalicylic acid desensitization in patients with coronary artery disease: A comprehensive overview of currently available protocols.

H. Suryapranata, G. De Luca, L. Barbieri, 2016, Vascular pharmacology.

H. Suryapranata, D. Kandzari, G. Musumeci, 2014, Open Heart.

P. Damman, M. Klomp, M. Beijk, 2011, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Abstract 6000: Clinical Outcome for the Endothelial Progenitor Cells Capturing Genous Stent: First Results of the 1-Year Follow-Up in 5000 Patients

S. Silber, E. Ribeiro, H. Suryapranata, 2008 .

Symptom-onset-to-balloon time and mortality in patients with acute myocardial infarction treated by primary angioplasty.

H. Suryapranata, M. de Boer, J. Hoorntje, 2003, Journal of the American College of Cardiology.

PexeLizumab for Acute ST-elevation myocardial infarction in patients undergoing primary percutaneous coronary intervention: A randomized controlled trial

Ajai Kumar Jain, P. Armstrong, F. Van de Werf, 2007 .

Outcomes After Complex PCI With COMBO Stent Implantation: Insights from a Real-World Pooled Dataset.

H. Suryapranata, R. D. de Winter, G. Dangas, 2023, The American journal of cardiology.

Drug-eluting vs bare-metal stents in primary angioplasty: a pooled patient-level meta-analysis of randomized trials.

G. Stone, H. Suryapranata, M. Schalij, 2012, Archives of internal medicine.

Does angiography six months after coronary intervention influence management and outcome? Benestent II Investigators.

P. Serruys, H. Suryapranata, F. Fernández‐Avilés, 1999, Journal of the American College of Cardiology.

A multi-site coronary sampling study on CRP in non-STEMI: Novel insights into the inflammatory process in acute coronary syndromes.

H. Suryapranata, F. Verheugt, S. Damen, 2018, Atherosclerosis.

Meta-analysis comparing efficacy and safety of first generation drug-eluting stents to bare-metal stents in patients with diabetes mellitus undergoing primary percutaneous coronary intervention.

G. Stone, H. Suryapranata, M. Schalij, 2013, The American journal of cardiology.

Predictive value of reactive hyperemic response on reperfusion on recovery of regional myocardial function after coronary angioplasty in acute myocardial infarction.

P. Serruys, H. Suryapranata, P. D. de Feyter, 1994, Circulation.

Recovery of regional myocardial dysfunction after successful coronary angioplasty early after a non-Q wave myocardial infarction.

P. Serruys, H. Suryapranata, J. Roelandt, 1990, American heart journal.

Predictors and outcome of grade 3 ischemia in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.

H. Suryapranata, Y. Birnbaum, C. Hamm, 2011, Journal of electrocardiology.

Coronary artery bypass grafting early after acute myocardial infarction in patients initially treated with thrombolytic therapy or coronary angioplasty

H. Suryapranata, M. de Boer, J. Hoorntje, 1994, Coronary artery disease.

Prognostic implications of myocardial injury around percutaneous coronary interventions

J. Ottervanger, H. Suryapranata, J. Hoorntje, 2008 .

Impact of chronic obstructive pulmonary disease on short-term outcome in patients with ST-elevation myocardial infarction during COVID-19 pandemic: insights from the international multicenter ISACS-STEMI registry

H. Suryapranata, G. De Luca, C. von Birgelen, 2022, Respiratory Research.

Coronary angioplasty for unstable angina: immediate and late results in 200 consecutive patients with identification of risk factors for unfavorable early and late outcome.

P. Serruys, H. Suryapranata, P. D. de Feyter, 1988, Journal of the American College of Cardiology.

A comparison between upfront high-dose tirofiban versus provisional use in the real-world of non-selected STEMI patients undergoing primary PCI

J. Ottervanger, H. Suryapranata, J. Hoorntje, 2010, Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation.

Sex Differences in Revascularization, Treatment Goals, and Outcomes of Patients With Chronic Coronary Disease: Insights From the ISCHEMIA Trial

J. Spertus, H. Suryapranata, A. Bagai, 2024, Journal of the American Heart Association.

Long-term results of the randomized comparison of everolimus-eluting stents and sirolimus-eluting stent in patients with ST elevation myocardial infarction (RACES-MI trial).

H. Suryapranata, V. Palmieri, G. De Luca, 2016, International journal of cardiology.

The effect of completeness of revascularization on event-free survival at one year in the ARTS trial.

P. Serruys, E. Ribeiro, H. Suryapranata, 2002, Journal of the American College of Cardiology.

Transiently achieved very low low-density lipoprotein cholesterol levels by statin and alirocumab after acute coronary syndrome are associated with cardiovascular risk reduction: the ODYSSEY OUTCOMES trial

Pedro F. Campos, Luciano Lopes de Sousa, Howard D. Rubenstein, 2023, European heart journal.

Impact of on-pump and off-pump coronary artery bypass grafting on 10-year mortality versus percutaneous coronary intervention

P. Serruys, H. Suryapranata, S. Garg, 2023, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

Elevated Homocysteine and the Risk of Contrast-Induced Nephropathy

H. Suryapranata, G. Niccoli, P. Marino, 2015, Angiology.

The predictive value of cumulative lactate dehydrogenase release within the first 72 h of acute myocardial infarction in patients treated with primary angioplasty

H. Suryapranata, M. de Boer, J. Hoorntje, 2004, Annals of clinical biochemistry.